PREDICTING MEASURABLE RESIDUAL DISEASE FOR ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS POSTTRANSPLANTATION

被引：0
|
作者：
Wang, Yue-Wen [1 ,2 ]
Fu, Guo-Mei [1 ,2 ]
Xu, Lan-Ping [1 ,2 ]
Wang, Yu [1 ,2 ]
Cheng, Yi-Fei [1 ,2 ]
Zhang, Yuan-Yuan [1 ,2 ]
Zhang, Xiao-Hui [1 ,2 ]
Liu, Yan-Rong [1 ,2 ]
Liu, Kai-Yan [1 ,2 ]
Huang, Xiao-Jun [1 ,2 ]
Chang, Ying-Jun [1 ,2 ]
机构：
[1] Peking Univ Peoples Hosp, Beijing, Peoples R China
[2] Peking Univ Inst Hematol, Beijing, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P516
引用
收藏
页码：498 / 498
页数：1
相关论文
共 50 条
  • [1] Risk Factors for Positive Posttransplantation Measurable Residual Disease in Patients with Acute Lymphoblastic Leukemia
    Wang, Yuewen
    Fu, Guomei
    Xu, Lanping
    Wang, Yu
    Cheng, Yi-Fei
    Zhang, Yuanyuan
    Zhang, Xiaohui
    Liu, Yanrong
    Liu, Kaiyan
    Huang, Xiao-Jun
    Chang, Ying-Jun
    BLOOD, 2023, 142
  • [2] Evaluation and management of measurable residual disease in acute lymphoblastic leukemia
    Abou Dalle, Iman
    Jabbour, Elias
    Short, Nicholas J.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [3] Clinical Value of Measurable Residual Disease in Acute Lymphoblastic Leukemia
    Hein, Kyaw
    Short, Nicholas
    Jabbour, Elias
    Yilmaz, Musa
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2022, 12 : 7 - 16
  • [4] Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients
    Saygin, Caner
    Cannova, Joseph
    Stock, Wendy
    Muffly, Lori
    HAEMATOLOGICA, 2022, 107 (12) : 2783 - 2793
  • [5] Measurable Residual Disease in Acute Lymphoblastic Leukemia: Techniques and Therapeutic Utility
    Muffly, Lori
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (07) : 419 - 421
  • [6] Molecular and cellular markers for measurable residual disease in acute lymphoblastic leukemia
    Juarez-Avendano, Gerardo
    Mendez-Ramirez, Nereida
    Luna-Silva, Nuria C.
    Gomez-Almaguer, David
    Pelayo, Rosana
    Balandran, Juan C.
    BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2021, 78 (03): : 159 - 170
  • [7] Measurable residual disease in acute lymphoblastic leukemia: How low is low enough?
    Logan, Aaron C.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022, 35 (04)
  • [8] Measurable Residual Disease in Acute Lymphoblastic Leukemia: Optimization and Innovation in 2021 and Beyond
    Muffly, Lori
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S85 - S87
  • [9] Measurable Residual Disease (MRD)-directed therapy for Acute Lymphoblastic Leukemia (ALL)
    Nagafuji, Koji
    CANCER SCIENCE, 2025, 116 : 1797 - 1797
  • [10] Measurable residual disease in childhood B-cell acute lymphoblastic leukemia
    Gale, Robert Peter
    BLOOD SCIENCE, 2022, 4 (04): : 209 - 210
12345